Align Technology (ALGN)

Overall impact
B (68)

Commentary

Align Technology is a strong overall performer. With a 'B' rating of 68.2 for overall impact (79th percentile compared to all companies), Align Technology ranks 65th out of 155 industry peers, behind American Shared Hospital Services, Accuray, BioSig Technologies and 61 others, and ahead of Hologic, Avinger, Adm Tronics Unlimited and 87 others. On top material causes for Align Technology's industry (Healthcare Equipment), Align Technology performs well in Accountable Institutions (81.4 score), Accountable Institutions (85.4), Sanitation Access (95.5) and 3 other causes where it received an 'A' score and performs poorly in Reduced Inequality (31.3 score) and Racial Justice and Civil Rights (27.9).
Impact
Cause ALGN
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1997
Employees
20,290
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Az, United States
Share classes
ALGN
Mission
Dedicated to transforming lives by improving the journey to a healthy, beautiful smile.
Description
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including the Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients. This segment also provides Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years with a mixture of primary/baby and permanent teeth. Additionally, this segment includes Invisalign express, Invisalign lite, and Invisalign moderate; as well as Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. The Imaging Systems and CAD/CAM Services segment offers the iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing (CAD/CAM) software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also provides the Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; the Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. The company was incorporated in 1997.
Material causes
Ethos considers the following causes material for Align Technology, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.